Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 14 entities : Sanofi save search
Sanofi: Information concerning the total number of voting rights and shares – October 2022
Published: 2022-11-14 (Crawled : 23:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: 0.0%
mRNA Vaccines and RNAi Therapeutics Market Report 2022: Government Initiatives for Large Scale Sequencing Projects Fueling Growth
Published: 2022-11-14 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
SGMO | News | $0.4989 -4.22% 880K
|
Health Technology
|
| O: -0.25%
H: 1.49%
C: -2.49%
report mrna therapeutics growth market
Global Cold Pain Therapy Market Report (2022 to 2027) - Growing Use of Cold Pain Therapy Among Middle-Aged Women Presents Opportunities
Published: 2022-11-14 (Crawled : 15:20) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
JNJ | News | $148.515 -0.7% 4.3M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
CAH | $103.33 -0.04% 1M
|
Distribution Services
|
| O: 0.37%
H: 1.84%
C: -0.45%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
global report women growing therapy market
MoonLake Immunotherapeutics Reports Third Quarter 2022 Financial Results and Provides Recent Business Update
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
financial update results
BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore
Published: 2022-11-14 (Crawled : 02:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -1.61%
H: 6.39%
C: 5.49%
global mrna
Innovent Presents Clinical Data of Phase Ia Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 Chinese Society of Clinical Oncology (CSCO) Annual Meeting
Published: 2022-11-14 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
LLY | News | $735.1 -1.42% 1.2M
|
Health Technology
|
| O: 1.92%
H: 0.48%
C: -0.84%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
INCY | $51.76 0.21% 600K
|
Health Technology
|
| O: 0.22%
H: 0.86%
C: -0.79%
ibi351 meeting chinese tumors study
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.87 59.83% 100M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.